Literature DB >> 7694813

Differentiation of proteinuria and haematuria by single protein analysis in urine.

W G Guder1, W Hofmann.   

Abstract

Single proteins and tubular enzymes have been proposed as markers to detect and differentiate prerenal, glomerular, tubular, and postrenal forms of proteinuria and haematuria. By quantitation of total protein, albumin, alpha 1-microglobulin, IgG, alpha 2-macroglobulin, and N-acetyl-beta, D-glucosaminidase (beta-NAG) activity it has become possible to clearly separate these forms by analysis of a single sample of second morning urine. When this program was applied to screening of hospital patients, albumin, total protein, and NAG proved to be sufficient to exclude clinically relevant disturbances. alpha 1-Microglobulin was useful to separate primary glomerulopathies from tubulo-interstitial diseases. Glomerular and postrenal haematuria could be clearly separated by their different excretion rates of alpha 2-macroglobulin, when urine albumin concentration exceeds 100 mg/L. The results imply that wider application of these techniques can help to detect renal abnormalities at an earlier stage and differentiate the various forms by less invasive techniques.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694813     DOI: 10.1016/0009-9120(93)90125-p

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Molecular cloning and characterization of a novel carboxylesterase-like protein that is physiologically present at high concentrations in the urine of domestic cats (Felis catus).

Authors:  Masao Miyazaki; Katsuyoshi Kamiie; Satoshi Soeta; Hideharu Taira; Tetsuro Yamashita
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 2.  [Hematuria in cases of bladder cancer].

Authors:  F Wawroschek; S Roth
Journal:  Urologe A       Date:  2003-02-25       Impact factor: 0.639

Review 3.  Proteinuria in Dent disease: a review of the literature.

Authors:  Youri van Berkel; Michael Ludwig; Joanna A E van Wijk; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2016-10-18       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.